intestinal failure Clinical Trials

8 recruitingLast updated: May 11, 2026

There are 8 actively recruiting intestinal failure clinical trials across 5 countries. Studies span Not Applicable, Phase 2. Top locations include Seattle, Washington, United States, Boston, Massachusetts, United States, Durham, North Carolina, United States. Updated daily from ClinicalTrials.gov.


intestinal failure Trials at a Glance

8 actively recruiting trials for intestinal failure are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Seattle, Boston, and Durham. Lead sponsors running intestinal failure studies include Institute of Oncology Ljubljana, Jinling Hospital, China, and Boston Children's Hospital.

Browse intestinal failure trials by phase

Treatments under study

About intestinal failure Clinical Trials

Looking for clinical trials for intestinal failure? There are currently 5 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new intestinal failure trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about intestinal failure clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Not Applicable

Effect of GLP-1 on Intestinal Barrier Function in SBS-IF Patients: A Preliminary Exploration.

intestinal failureShort Bowel Syndrome (SBS)
Jinling Hospital, China20 enrolled2 locationsNCT07297238
Recruiting

Prospective Multisite Study of Quality of Life in Pediatric Intestinal Failure

Pediatric Intestinal Failure
Boston Children's Hospital750 enrolled14 locationsNCT04629014
Recruiting
Not Applicable

Anabolic Response To Intravenous Amino Acids In Chronic Intestinal Failure Patients

intestinal failureChronic Intestinal FailureHome Parenteral Nutrition
Institute of Oncology Ljubljana40 enrolled1 locationNCT07422792
Recruiting
Not Applicable

AI-driven Total Parenteral Nutrition Platform

intestinal failure
Takeoff41, Inc.260 enrolled1 locationNCT07414576
Recruiting
Not Applicable

KiteLock 4% EDTA Lock Solution for the Prevention of Occlusions in Children With Intestinal Failure

Pediatric Intestinal Failure
SterileCare Inc.124 enrolled8 locationsNCT05879835
Recruiting

VALidation of Imaging-based Liver Biomarkers in PEDiatric Patients

MAFLDHepatic DisordersIntestinal Failure-associated Liver Disease+2 more
Sahlgrenska University Hospital550 enrolled1 locationNCT07202910
Recruiting
Phase 2

A Study of NST-6179 in Subjects With Intestinal Failure-Associated Liver Disease (IFALD).

Intestinal Failure-associated Liver Disease
NorthSea Therapeutics B.V.36 enrolled13 locationsNCT05919680
Recruiting

Weaning is Winning? (WeWin Study)

intestinal failureparenteral nutrition
The Hospital for Sick Children120 enrolled1 locationNCT06525753